Table 1 Main data distribution table of the EHR dataset.
No. | Gender | Age | Stage | Molecular subtype | Chemical therapy | Radiation therapy | Endocrine therapy | Target therapy |
|---|---|---|---|---|---|---|---|---|
1 | Female | 64 | Stage IA | Luminal-B HER-2 positive | Yes | No | Aromatase inhibitor | No |
2 | Female | 55 | Stage IA | Luminal-B HER-2 negative | Yes | Yes | Tamoxifen | No |
3 | Female | 65 | Stage IB | Luminal-B HER-2 negative | Yes | Yes | Aromatase inhibitor | No |
4 | Female | 44 | Stage IIA | Triple negative | Yes | Yes | - | No |
5 | Female | 46 | Stage IIA | Luminal-A | Yes | Yes | Toremifene | No |
6 | Female | 47 | Stage IIB | Luminal-B HER-2 negative | Yes | No | Toremifene | No |
7 | Female | 76 | Stage IIIA | Triple negative | Yes | No | No | - |
8 | Female | 58 | Stage IIIB | Luminal-A | Yes | Yes | Tamoxifen | No |
9 | Female | 56 | Stage IIIC | Triple negative | Yes | Yes | - | No |
10 | Female | 66 | Stage IV | Luminal-B HER-2 positive | Yes | Yes | Aromatase inhibitor | No |
